Safety and efficacy of theterminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd phase III clinical study results

被引：0
|
作者：
Schrezenmeier, H.
Luzzatto, L.
Rotoli, B.
Young, N. S.
Schubert, J.
Urbano-Ispizua, A.
Coyle, L.
DeCastro, C.
Fu, C. L.
Maciejewski, J. P.
Kroon, H. A.
Rother, R. P.
Hillmen, P.
机构：
[1] Univ Hosp Ulm, Ulm, Germany
[2] Ist Toscano Tumori, Florence, Italy
[3] Poloclin Napoli Federico II, Naples, Italy
[4] NHLBI, Bethesda, MD 20892 USA
[5] Univ Saarland, Sch Med, D-6650 Homburg, Germany
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Royal N Shore Hosp, St Leonards, NSW 2065, Australia
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Cleveland Clin, Weston, FL USA
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Alexion Pharmaceut Inc, Cheshire, CT USA
[12] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0378
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH): Shepherd phase III clinical study results
    Risitano, A. M.
    Hillmen, P.
    Young, N. S.
    Schrezenmeier, H.
    Schubert, J.
    Urbano-Ispizua, A.
    Coyle, L.
    de Castro, C.
    Fu, C. L.
    Maciejewski, J. P.
    Di Bona, E.
    Antonioli, E.
    Gianfaldoni, G.
    Milano, F.
    Amendola, A.
    Kroon, H. A.
    Rother, R. P.
    Zanella, A.
    Rodeghiero, F.
    Iori, A. P.
    Luzzatto, L.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
  • [2] Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Interim shepherd phase III clinical study.
    Young, Neal S.
    Antonioli, Elisabetta
    Rotoli, Bruno
    Schrezenmeier, Hubert
    Schubert, Joerg
    Urbano-Ispizua, Alvaro
    Coyle, Luke
    de Castro, Carlos
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw P.
    Mojcik, Christopher F.
    Rother, Russell P.
    Hillmen, Peter
    BLOOD, 2006, 108 (11) : 290A - 290A
  • [3] Theterminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P.
    Muus, P.
    Duehrsen, U.
    Risitano, A.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Hill, A.
    Socie, G.
    Bessler, M.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 138 - 138
  • [4] Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria: AEGIS Phase II Clinical Study Results
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-Ichi
    Kinoshita, Taroh
    Bedrosian, Camille
    Valentine, Marye Ellen
    Ozawa, Keiya
    Omine, Mitsuhiro
    BLOOD, 2008, 112 (11) : 1179 - 1179
  • [5] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Yuzuru Kanakura
    Kazuma Ohyashiki
    Tsutomu Shichishima
    Shinichiro Okamoto
    Kiyoshi Ando
    Haruhiko Ninomiya
    Tatsuya Kawaguchi
    Shinji Nakao
    Hideki Nakakuma
    Jun-ichi Nishimura
    Taroh Kinoshita
    Camille L. Bedrosian
    Marye Ellen Valentine
    Gus Khursigara
    Keiya Ozawa
    Mitsuhiro Omine
    International Journal of Hematology, 2011, 93 : 36 - 46
  • [6] Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial
    Kanakura, Yuzuru
    Ohyashiki, Kazuma
    Shichishima, Tsutomu
    Okamoto, Shinichiro
    Ando, Kiyoshi
    Ninomiya, Haruhiko
    Kawaguchi, Tatsuya
    Nakao, Shinji
    Nakakuma, Hideki
    Nishimura, Jun-ichi
    Kinoshita, Taroh
    Bedrosian, Camille L.
    Valentine, Marye Ellen
    Khursigara, Gus
    Ozawa, Keiya
    Omine, Mitsuhiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (01) : 36 - 46
  • [7] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [8] EFFICACY OF THE COMPLEMENT INHIBITOR ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS NEVER TRANSFUSED
    Risitano, A.
    Alfinito, F.
    Seneca, E.
    Marando, L.
    Boschetti, C.
    Bonfigli, S.
    Fenu, S.
    Re, F.
    Gosetti, G.
    Khursigara, G.
    Rother, R.
    Zanella, A.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 237 - 237
  • [9] Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
    Brodsky, Robert A.
    Young, Neal S.
    Antonioli, Elisabetta
    Risitano, Antonio M.
    Schrezenmeier, Hubert
    Schubert, Jorg
    Gaya, Anna
    Coyle, Luke
    De Castro, Carlos
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw P.
    Bessler, Monica
    Kroon, Henk-Andre
    Rother, Russell P.
    Hillmen, Peter
    BLOOD, 2008, 111 (04) : 1840 - 1847
  • [10] Treatment with the terminal complement inhibitor eculizumab improves anemia in patients with paroxysmal nocturnal hemoglobinuria:: Phase III triumph study results.
    Schubert, Joerg
    Hillmen, Peter
    Duehrsen, Ulrich
    Young, Neal S.
    Elebute, Modupe
    Szer, Jeffrey
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Mojcik, Christopher F.
    Rother, Russell P.
    Muus, Petra
    BLOOD, 2006, 108 (11) : 41A - 41A
12345